nach oben

Neurological Sciences

Erschienen in:

27.08.2021 | Original Article

Effect of ketogenic diet for drug-resistant epilepsy on immunological cells

verfasst von: May Fouad Nassar, Yasmin Gamal Abdou El-Gendy, Mohamed Tarif Hamza, Marwa Nasser Mohamed, Nesrine Radwan

Erschienen in: Neurological Sciences | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Background and aim of the work

Ketogenic diet (KD) is one of the treatments in drug-resistant epilepsy (DRE). The current study aimed at assessing the effect of KD-induced ketosis on different immunological cells since ketosis is reported to affect neutrophil function.

Methodology

We recruited 21 pediatric patients diagnosed with DRE assigned to start KD. Anthropometric measurements, complete blood picture with differential count, phagocytic function, lymphocyte subsets, and IgG estimation were estimated initially and after 6 months of KD.

Results

There were no differences between the initial total leucocytic, neutrophil, and lymphocytic counts as well as the lymphocyte subsets, and the values after 6 months of KD. IgG values showed significant increase yet the values were still within the reference ranges. For the innate immune system, the phagocytic index was assessed and it showed a marked statistical reduction in patients after KD.

Conclusion

KD has no effect on neutrophil and lymphocytic counts as well as the number of adaptive and immune cells; nevertheless, it causes a reduction in phagocytic index in DRE. Accordingly, further detailed study for the full immunological profile and function is needed to ensure the safety of this therapeutic line and correlate it with the clinical history.

Nur mit Berechtigung zugänglich

Picot M-C, Baldy-Moulinier M, Daurs J-P, Dujols P, Crespel A (2008) The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 49(7):1230–1238CrossRef

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51(6):1069–1077CrossRef

Mehdizadeh A, Barzegar M, Negargar S, Yahyavi A, Raeisi S (2019) The current and emerging therapeutic approaches in drug-resistant epilepsy management. Acta Neurol Belg 119:155–162. https://doi.org/10.1007/s13760-019-01120-8CrossRefPubMed

Hartman AL, Vining EPG (2007) Clinical aspects of the ketogenic diet. Epilepsia 48(1):31–42CrossRef

Rho JM (2017) How does the ketogenic diet induce anti-seizure effects? Neurosci Lett 10(637):4–10CrossRef

D’AndreaMeira I, Romão TT, Pires do Prado HJ, Krüger LT, Pires MEP, da Conceição PO (2019) Ketogenic diet and epilepsy: what we know so far. Front Neurosci 29(13):5CrossRef

Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA (2006) Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol 21(3):193–198CrossRef

El-Rashidy OF, Nassar MF, Abdel-Hamid IA, Shatla RH, Abdel-Hamid MH, Gabr SS et al (2013) Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol Scand 128(6):402–408CrossRef

El Rashidy OF, Nassar MF, El Gendy YG, Deifalla SM, Gaballa S (2018) Experience with MAD on children with epilepsy in Egypt after classic KD failure. Acta Neurol Scand 137(2):195–198CrossRef

10.

Hobdell EF, Tonyes L (2007) Diets for epilepsy. Touch Briefings: US Pediatric Review 2:45–46

11.

Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R et al (2009) Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 50(2):304–317CrossRef

12.

Klebanoff SJ, Clark RA (1978) The neutrophil: ffunction and clinical disorders. Elsevier/North-Holland Biomedical, Amsterdam

13.

Saeed FA, Castle GE (1998) Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: implications for diabetic susceptibility to infections. Clin Diagn Lab Immunol 5(5):740–743CrossRef

14.

Freeman JM, Kossoff EH, Hartman AL (2007) The ketogenic diet: one decade later. Pediatrics 119(3):535–543CrossRef

15.

Bueno NB, de Melo ISV, de Oliveira SL, da Rocha Ataide T (2013) Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr 110(7):1178–1187

16.

Lambrechts DAJE, de Kinderen RJA, Vles JHS, de Louw AJA, Aldenkamp AP, Majoie HJM (2016) A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol Scand. https://doi.org/10.1111/ane.12592CrossRefPubMed

17.

Beniczky S, Miranda MJ, Alving J, Povlsen JH, Wolf P (2009) Effectiveness of the ketogenic diet in a broad range of seizure types and EEG features for severe childhood epilepsies. Acta Neurol Scand. https://doi.org/10.1111/j.1600-0404.2009.01303.xCrossRefPubMed

18.

Tekin E, Serdaroğlu FM, Şahin Ş et al (2020) Ketogenic diet experience at Ondokuz Mayıs University. Neurol Sci. https://doi.org/10.1007/s10072-020-04853-0CrossRefPubMed

19.

Woody RC, Steele RW, Knapple WL, Pilkington NS Jr (1989) Impaired neutrophil function in children with seizures treated with the ketogenic diet. J Pediatr 115(3):427–430CrossRef

20.

Harrison JE, Schultz J (1976) Studies on the chlorinating mechanism of myeloperoxidase. J Biol Chem 251(5):1371–1374CrossRef

21.

McMurray RW, Bradsher RW, Steele RW, Pilkington NS (1990) Effect of prolonged modified fasting in obese persons on in vitro markers of immunity: lymphocyte function and serum effects on normal and neutrophils. Am J Med Sci 299(6):379–385CrossRef

22.

Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, Wang C et al (2017) β-Hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep 18(9):2077–2087CrossRef

23.

Schreck KC, Lwin MY, Strowd RE, Henry-Barron BJ, Blakeley JO, Cervenka MC (2019) Effect of ketogenic diets on leukocyte counts in patients with epilepsy. Nutr Neurosci 22(7):522–527CrossRef

24.

Fraser DA, Thoen J, Bondhus S, Haugen M, Reseland JE, Djøseland O et al (2000) Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients. Clin Exp Rheumatol 18(2):209–214PubMed

25.

Pardo AC (2020) Ketogenic diet: a role in immunity? Pediatr Neurol Briefs 34:5CrossRef

Titel: Effect of ketogenic diet for drug-resistant epilepsy on immunological cells
verfasst von: May Fouad Nassar
Yasmin Gamal Abdou El-Gendy
Mohamed Tarif Hamza
Marwa Nasser Mohamed
Nesrine Radwan
Publikationsdatum: 27.08.2021
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 3/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05574-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background and aim of the work

Methodology

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report

Postural tremor in L-2-hydroxyglutaric aciduria is associated with cerebellar atrophy

The first case of infantile-onset multisystem neurologic, endocrine, and pancreatic disease caused by novel PTRH2 mutation in Japan

Short- and long-term motor outcome of STN-DBS in Parkinson’s Disease: focus on sex differences

Cerebral venous thrombosis: a retrospective unicentric analysis of clinical and neuroimaging characteristics

Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis